Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that the ...
inc425h
Delhi HC Orders Amazon To Pay INR 339 Cr For Copyright Infringement
The Delhi HC has ordered big tech giant Amazon to pay damages worth INR 339.3 Cr to Lifestyle Equities for alleged copyright ...